Publications by authors named "S E Beekmann"

Article Synopsis
  • - There is a significant need to assess the knowledge and training gaps among infectious disease (ID) physicians regarding encephalitis, specifically autoimmune encephalitis.
  • - A survey was conducted among European ID specialists, with 201 respondents indicating that 64% dealt with infectious encephalitis, while only 7.5% focused on autoimmune cases.
  • - Many physicians reported low confidence in recognizing (60%), diagnosing (71%), and treating (85%) autoimmune encephalitis, highlighting the demand for standardized guidelines from ESCMID for better management practices (89%).
View Article and Find Full Text PDF

Antiviral therapy is underutilized for outpatients at increased risk for severe COVID-19 or influenza. Results from this survey offer insights into treatment barriers from the infectious disease specialist perspective. Further education is needed about the benefits of early antiviral therapy.

View Article and Find Full Text PDF
Article Synopsis
  • - A survey of US infectious disease specialists found that 61 reported cases of Bartonella quintana infections from 2014 to 2024.
  • - Key challenges in diagnosing these infections are a lack of awareness among healthcare providers, insufficient testing, and uneven access to healthcare for affected groups.
  • - To enhance patient outcomes, it's crucial to improve early recognition of B. quintana infections.
View Article and Find Full Text PDF

A survey of US infectious disease physicians indicated that few regularly reviewed wastewater surveillance (WWS) data but many reported examples of how WWS has affected or could affect their clinical practice. WWS data can be useful for physicians, but increased communication between public health professionals and physicians regarding WWS could improve its utility.

View Article and Find Full Text PDF

Antifungal-resistant dermatophyte infections have recently emerged as a global public health concern. A survey of US infectious diseases specialists found that only 65% had heard of this issue and just 39% knew how to obtain testing to determine resistance. Increased clinician awareness and access to testing for antifungal-resistant dermatophytosis are needed.

View Article and Find Full Text PDF